Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00646711 · ClinicalTrials.gov registry record · Phase 2
Pediatric Switch Study for Children and Adolescent Patients With Epilepsy
A Phase 2 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT00646711 is a Phase 2 study that has completed, run by Abbott. The registered enrollment target is 16 participants.
The verdict
NCT00646711, a Phase 2 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
To assess the tolerability of switching from Depakote Sprinkle Capsules or Depakote tablets to Depakote ER tablets in the pediatric population.
Interventions
- DRUG Depakote ER
- DRUG Depakote Delayed-Release/Depakote Sprinkle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2003-02 |
| Est. Completion | 2003-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00646711
The ClinicalTrials.gov registry entry for NCT00646711 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Depakote ER is the first listed.
NCT00646711 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00646711 about?
NCT00646711 is a clinical study titled "Pediatric Switch Study for Children and Adolescent Patients With Epilepsy". To assess the tolerability of switching from Depakote Sprinkle Capsules or Depakote tablets to Depakote ER tablets in the pediatric population.
What is the current status of trial NCT00646711?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2003-02. Estimated completion is 2003-12.
What interventions are being tested in trial NCT00646711?
The interventions under investigation include: Depakote ER (DRUG), Depakote Delayed-Release/Depakote Sprinkle (DRUG).
Who is sponsoring clinical trial NCT00646711?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.